Clinical parameters of ovarian hyperstimulation syndrome following different hormonal triggers of oocyte maturation in IVF treatment

Clinical Parameters ◽

Ovarian Hyperstimulation

A comparison of Ovarian Hyperstimulation Syndrome (OHSS) parameters following different triggers of oocyte maturation during IVF Treatment

Endocrine Abstracts ◽

10.1530/endoabs.50.p352 ◽

2017 ◽

Author(s):

SA Clarke ◽

A Abbara ◽

R Islam ◽

L Jeffers ◽

G Christopoulos ◽

...

Keyword(s):

Oocyte Maturation ◽

Ovarian Hyperstimulation

Faculty Opinions recommendation of Oocyte maturation employing a GnRH agonist in combination with low-dose hCG luteal rescue minimizes the severity of ovarian hyperstimulation syndrome while maintaining excellent pregnancy rates.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13991957.15448065 ◽

2012 ◽

Author(s):

Björn Heindryckx ◽

Frauke Vanden Meerschaut

Keyword(s):

Oocyte Maturation ◽

Gnrh Agonist ◽

Low Dose ◽

Pregnancy Rates ◽

Low Dose Hcg

Implementing two strategies to avoid ovarian hyperstimulation syndrome (OHSS): use of GnRH agonists (GnRHa) to trigger final oocyte maturation associated with blastocyst cryopreservation

Fertility and Sterility ◽

10.1016/j.fertnstert.2013.07.244 ◽

2013 ◽

Vol 100 (3) ◽

pp. S517-S518

Author(s):

M.M. Carneiro ◽

A.L.M. Silva ◽

A.M.M. Cota ◽

J.P.J. Caetano

Keyword(s):

Oocyte Maturation ◽

Gnrh Agonists ◽

Final Oocyte Maturation

Final oocyte maturation with two different GnRH agonists in antagonist co-treated cycles at risk of ovarian hyperstimulation syndrome

Reproductive BioMedicine Online ◽

10.1016/j.rbmo.2016.10.004 ◽

2017 ◽

Vol 34 (1) ◽

pp. 5-10 ◽

Cited By ~ 3

Author(s):

Yavuz Emre Şükür ◽

Batuhan Özmen ◽

Elif Didem Özdemir ◽

Mehmet Murat Seval ◽

Erkan Kalafat ◽

...

Keyword(s):

At Risk ◽

Oocyte Maturation ◽

Gnrh Agonists ◽

Final Oocyte Maturation

Recombinant vs. urinary human chorionic gonadotrophin (hCG) for triggering final oocyte maturation in patients at risk for ovarian hyperstimulation syndrome OHSS: a randomized clinical trial

10.26226/morressier.573c1514d462b80296c98c10 ◽

2016 ◽

Author(s):

Georgios Lainas

Keyword(s):

Clinical Trial ◽

At Risk ◽

Randomized Clinical Trial ◽

Oocyte Maturation ◽

Chorionic Gonadotrophin ◽

Human Chorionic Gonadotrophin ◽

Final Oocyte Maturation ◽

Patients At Risk

GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: still a controversy?

Journal of Assisted Reproduction and Genetics ◽

10.1007/s10815-008-9198-1 ◽

2008 ◽

Vol 25 (2-3) ◽

pp. 63-66 ◽

Cited By ~ 25

Author(s):

S. Kol ◽

I. Solt

Keyword(s):

At Risk ◽

Oocyte Maturation ◽

Gnrh Agonist ◽

Final Oocyte Maturation ◽

Patients At Risk

A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols

Journal of Assisted Reproduction and Genetics ◽

10.1007/s10815-017-1074-4 ◽

2017 ◽

Vol 35 (2) ◽

pp. 297-307

Author(s):

Yanett Anaya ◽

Douglas A. Mata ◽

Joseph Letourneau ◽

Hakan Cakmak ◽

Marcelle I. Cedars ◽

...

Keyword(s):

In Vitro Fertilization ◽

Oocyte Maturation ◽

Chorionic Gonadotropin ◽

Human Chorionic Gonadotropin ◽

Follicle Stimulating Hormone ◽

Vitro Fertilization ◽

Stimulating Hormone

Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy

The Journal of Clinical Endocrinology & Metabolism ◽

10.1210/jc.2015-2332 ◽

2015 ◽

Vol 100 (9) ◽

pp. 3322-3331 ◽

Cited By ~ 67

Author(s):

Ali Abbara ◽

Channa N. Jayasena ◽

Georgios Christopoulos ◽

Shakunthala Narayanaswamy ◽

Chioma Izzi-Engbeaya ◽

...

Keyword(s):

High Risk ◽

In Vitro Fertilization ◽

Oocyte Maturation ◽

Vitro Fertilization

The impact of using gonadotropin-releasing hormone agonist for triggering final oocyte maturation in antagonist-treated intracytoplasmic sperm injection cycles on women at high risk of developing ovarian hyperstimulation syndrome

Evidence Based Womenʼs Health Journal ◽

10.1097/01.ebx.0000482801.97372.5c ◽

2016 ◽

Vol 6 (3) ◽

pp. 85-89

Author(s):

Noura S. Elnassery ◽

Fouad A. Abuhamila

Keyword(s):

High Risk ◽

Oocyte Maturation ◽

Intracytoplasmic Sperm Injection ◽

Gonadotropin Releasing Hormone ◽

Releasing Hormone ◽

Gonadotropin Releasing Hormone Agonist ◽

Final Oocyte Maturation ◽

The Impact

Oocyte maturation employing a GnRH agonist in combination with low-dose hCG luteal rescue minimizes the severity of ovarian hyperstimulation syndrome while maintaining excellent pregnancy rates

Human Reproduction ◽

10.1093/humrep/der333 ◽

2011 ◽

Vol 26 (12) ◽

pp. 3437-3442 ◽

Cited By ~ 46

Author(s):

B. Radesic ◽

K. Tremellen

Keyword(s):

Oocyte Maturation ◽

Gnrh Agonist ◽

Low Dose ◽

Pregnancy Rates ◽

Low Dose Hcg